Christine Blank
FDA okays short-acting follow-on insulin for diabetes
FDA okays the first short-acting insulin approved as a “follow-on” product.
Integrated care can benefit pediatric asthmatics
A new study reveals interesting findings about improving the health of pediatric asthma patients and integrated care programs.
Does breastfeeding protect children against asthma?
While breastfeeding has been thought to decrease children’s risk of developing allergies and asthma, a new study counters that belief.
FDA okays new diabetes, asthma drugs
FDA recently approved a new diabetes medication, as well as a drug to treat severe asthma.
FDA approves first once-monthly injection for opioid abuse
Soon after FDA approved a novel device to treat opioid use disorder, FDA approved the first and only once-monthly injectable buprenorphine formulation to treat moderate to severe opioid use disorder (OUD).
New cancer biosimilar could net major sales
A new biosimilar to the cancer drug Herceptin, which raked in $2.5 billion in US sales last year, is expected to produce blockbuster sales in the US.
FDA approves breakthrough cancer gene test
FDA approved a new cancer biomarker test that can detect genetic mutations in 324 genes and 2 genomic signatures in tumors.
Two asthma treatment recommendations for health organizations
Allergist Bradley Chipps, MD, shares research on how to fine-tune asthma management strategies.
Landmark study identifies asthma in infants
A Canadian study reveals how clinicians may be able to identify whether asthma will develop in patients as young as age one.


View Results